Regadenoson and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Regadenoson (regadenoson), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zoloft, and have Chest pain.

The phase IV clinical study analyzes which people have Fainting when taking Regadenoson. It is created by eHealthMe based on reports of 357 people who have side effects when taking Regadenoson from the FDA, and is updated regularly.

What is Regadenoson?

Regadenoson has active ingredients of regadenoson. eHealthMe is studying from 357 Regadenoson users. Check the latest studies of Regadenoson.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,456 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Fainting.

On Jul, 17, 2026

357 people reported to have side effects when taking Regadenoson.
Among them, 12 people (3.36%) have Fainting.

Among these 12 people:

How long have people been on Regadenoson when they have Fainting? *

What is the gender of people who have Fainting when taking Regadenoson? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Fainting when taking Regadenoson? *

What are other drugs people take besides Regadenoson? *

What are other side effects people have besides Fainting? *

Nausea (feeling of having an urge to vomit): 4 people, 33.33%
Dizziness: 4 people, 33.33%
White Blood Cell Count Decreased: 3 people, 25.00%
Granuloma (a small area of inflammation due to tissue injury): 3 people, 25.00%
Hypokalemia (low potassium): 3 people, 25.00%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 25.00%
Hyperhidrosis (abnormally increased sweating): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Headache (pain in head): 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%

What are the existing conditions these people have? *

Chest Pain: 4 people, 33.33%
Stress And Anxiety: 3 people, 25.00%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 3 people, 25.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 25.00%
Polymyalgia Rheumatica (pain in many muscles): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Regadenoson and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Regadenoson:

Regadenoson (357 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Regadenoson:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,456 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on regadenoson (the active ingredients of Regadenoson) and Regadenoson (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.